Skip to content

Encinas Pharma

Active Risk: very low Private limited companyfounded 2025active for 1 yearGanzenweidestraat 186, 1130 BrusselsKBO/BCE: BE 1023.609.623
Encinas Pharma
Follow ReportCompare

Board

1 director, since incorporation
ENCINAS GARCIA Marie Neige Julia
Director (not named in the articles)
appointed by deed of 26-05-2025 term without a fixed end

Office holders in the KBO →

Mandates through the years

1 name, the dashed line is today
ENCINAS GARCIA Marie Neige Julia
Director (not named in the articles)
Board
Mandates as a list
  • ENCINAS GARCIA Marie Neige Julia
    • Director (not named in the articles), appointed by deed of 26-05-2025, still in office

Control

Founder
ENCINAS GARCIA Marie Neige Julia
This company
Encinas Pharma

Capital

Contribution
€5,000
Shares
100
Contribution per share
€50
Source
deed of 26-05-2025

Articles of association

deed of 26-05-2025 (in French)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Board ruleThese rules set how the board is made up, meets and takes decisions.
At least 1 director
Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
“Moitié cédant/moitié acquéreurs au prorata, mêmes formalités”
Financial yearThe company draws up its annual accounts over this twelve-month period.
From 1 October to 30 September
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Fourth Friday of February at 20:00

Founder

At incorporation deed of 26-05-2025 ↗

Next steps

See this company's board, registered office and name on a given date.Company as of a date See what became of the directors' other companies.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file

We would like to set cookies. That happens only with your consent. What we measure